CF101
Showing 1 - 25 of 550
Rheumatoid Arthritis Trial in Worldwide (CF101 1 mg, CF101 2 mg, Placebo)
Terminated
- Rheumatoid Arthritis
- CF101 1 mg
- +3 more
-
Banja Luka, Bosnia and Herzegovina
- +34 more
Dec 17, 2020
Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF) Trial in Poland, United States (MS1819, Porcine PERT)
Completed
- Exocrine Pancreatic Insufficiency (EPI)
- Cystic Fibrosis (CF)
- MS1819
- Porcine PERT
-
Long Beach, California
- +14 more
Dec 17, 2021
Advanced Follicular Lymphoma Trial in Worldwide (Obinutuzumab, Bendamustine, Cyclophosphamide)
Active, not recruiting
- Advanced Follicular Lymphoma
- Obinutuzumab
- +5 more
-
Boulder, Colorado
- +33 more
Nov 21, 2022
Metastatic Breast Cancer Trial in Worldwide (metastatic lesion biopsy)
Suspended
- Metastatic Breast Cancer
- metastatic lesion biopsy
-
Brussels, Belgium
- +59 more
Jan 17, 2023
Tuberous Sclerosis Complex Trial in United States (Basimglurant with crossover to Placebo, Placebo with crossover to
Recruiting
- Tuberous Sclerosis Complex
- Basimglurant with crossover to Placebo
- Placebo with crossover to Basimglurant
-
Phoenix, Arizona
- +47 more
Jan 3, 2023
HER2-ve Metastatic Breast Cancer, Germline BRCA1/2 Mutations, Somatic BRCA1/2 Mutations Trial in Worldwide (Olaparib)
Completed
- HER2-ve Metastatic Breast Cancer
- +2 more
-
Towson, Maryland
- +122 more
Dec 22, 2022
Body Weight, Body Fat, Overweight Trial (Vigiis 101 Lactobacillus Capsules, Placebo Capsules)
Not yet recruiting
- Body Weight
- +2 more
- Vigiis 101 Lactobacillus Capsules
- Placebo Capsules
- (no location specified)
May 18, 2023
Solid Tumor, Adult Trial (CF33-CD19 IT, CF33-CD19 IV, Blinatumomab)
Not yet recruiting
- Solid Tumor, Adult
- CF33-CD19 IT
- +2 more
- (no location specified)
Sep 26, 2023
Healthy Trial in Davis (CF Control, CF-Theobromine, CF-Caffeine)
Completed
- Healthy
- CF Control
- +2 more
-
Davis, California
- +1 more
Oct 6, 2022
Cystic Fibrosis Trial in Worldwide (inhaled mannitol, Placebo comparator)
Completed
- Cystic Fibrosis
- inhaled mannitol
- Placebo comparator
-
Tucson, Arizona
- +52 more
Oct 6, 2020
Early Breast Cancer Trial in Worldwide (drug, procedure, radiation)
Active, not recruiting
- Early Breast Cancer
- Cyclophosphamide
- +10 more
-
Rockville, Maryland
- +106 more
Jan 19, 2023
Cystic Fibrosis Lung Trial in United States (4D-710)
Recruiting
- Cystic Fibrosis Lung
- 4D-710
-
Denver, Colorado
- +5 more
Jul 14, 2022
Leukemia, Acute Lymphoblastic Trial in Worldwide (Omitted Doxorubicin, Omitted Vincristine+Dexamethasone pulses, Inotuzumab
Recruiting
- Leukemia, Acute Lymphoblastic
- Omitted Doxorubicin
- +5 more
-
Brussels, Belgium
- +100 more
Dec 12, 2022
Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation Trial (Sodium Fusidate, Placebo)
Not yet recruiting
- Cystic Fibrosis
- Cystic Fibrosis Pulmonary Exacerbation
- Sodium Fusidate
- Placebo
- (no location specified)
Dec 14, 2022
Squamous Cell Carcinoma (SCC), Recurrent or Metastatic, Platinum-refractory Cervical Cancer Trial in Worldwide (Cemiplimab,
Active, not recruiting
- Squamous Cell Carcinoma (SCC)
- Recurrent or Metastatic, Platinum-refractory Cervical Cancer
- Cemiplimab
- Investigator Choice (IC) Chemotherapy
-
Phoenix, Arizona
- +104 more
Mar 11, 2022
Tumors, Breast, Carcinoma of Breast, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Worldwide (niraparib,
Completed
- Neoplasms, Breast
- +5 more
- niraparib
- Physician's choice
-
Tucson, Arizona
- +103 more
Nov 2, 2021
Chronic Graft-versus-host Disease Trial in Worldwide (Itacitinib, Placebo, Methylprednisolone)
Active, not recruiting
- Chronic Graft-versus-host Disease
- Itacitinib
- +3 more
-
Tucson, Arizona
- +132 more
Oct 17, 2022
Cystic Fibrosis Reproductive and Sexual Health Collaborative:
Active, not recruiting
- Cystic Fibrosis
- Patient Engagement
- 4-part educational program to build patient-engagement methodology capacity
-
Seattle, WashingtonUniversity of Washington
Aug 13, 2021
Urothelial Cancer Trial in Worldwide (MEDI4736 (Durvalumab), Tremelimumab, Cisplatin)
Active, not recruiting
- Urothelial Cancer
- MEDI4736 (Durvalumab)
- +4 more
-
Los Angeles, California
- +221 more
Nov 2, 2022